Midday Movers: Intel's Israel Deal, Bristol-Myers Squibb Buys RayzeBio
Key TakeawaysU.S. equities continued their pre-Christmas rally in the last week of 2023, with the Dow, S&P 500, and Nasdaq all up.Intel received a 4.1 billion to buy RayzeBio as the drug maker moves to expand its cancer portfolio.Christmas may be over, but the so-called “Santa Claus rally” continued for U.S. equities at midday in the shortened final trading week of 2023. The Dow, S&P 500, ...